‘You’re going overboard’: Bombay high court to FDA, restores Cipla’s licence
Maharashtra FDA withdrew its cancellation of Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized the regulator for acting high-handedly and violating natural justice principles. The court allowed the FDA to issue a fresh show cause notice and conduct a proper hearing. Cipla's license cancellation had prevented critical medicines from reaching patients. The FDA's order was passed on a public holiday without a proper hearing.
